Download 2017 Membership Directory (PDF)
NANOVALENT PHARMACEUTICALS INC.NANOVALENT PHARMACEUTICALS INC.
NanoValent Pharmaceuticals Inc. (NVP) is a biotechnology company developing a highly stable, easily manufactured, platform drug delivery technology capable of delivering a wide array of pharmaceutical agents. This platform technology consists of biocompatible, targeted polymeric particles with substantial advantages over other particle/liposomal drug delivery systems. The company has three drug candidates ready for pre-IND trials. NVP will focus on several niche areas including cancer therapeutics (Ewing sarcoma and leukemia), vaccines and RNAi drug delivery.